We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Short Communication

Kuwanon X from mulberry leaves exhibits antiviral activity against human adenoviruses

    Chi Li

    Division of Infectious Disease, Shenzhen Children’s Hospital, Shenzhen, 518038, China

    ,
    Jikui Deng

    Division of Infectious Disease, Shenzhen Children’s Hospital, Shenzhen, 518038, China

    &
    Lifeng Qi

    *Author for correspondence: Tel.: +86 189 3869 0190;

    E-mail Address: qlf0298@sina.com

    Division of Infectious Disease, Shenzhen Children’s Hospital, Shenzhen, 518038, China

    Published Online:https://doi.org/10.2217/fvl-2023-0001

    Aim: This study aimed to investigate the anti-adenoviral activity of stilbene derivatives from mulberry leaves. Materials & methods: The anti-adenoviral activity was tested against adenoviruses -3 and -7 on human airway epithelial cell models. Cytotoxicity was assessed by LDH assay. Adenoviral DNA was quantified by qPCR. Results: All five tested stilbene derivatives from mulberry leaves exhibited anti-adenoviral activity, with Kuwanon X showing the highest inhibitory effect. Kuwanon X showed no apparent cytotoxicity for a wide range of concentrations. The mechanistic study revealed that Kuwanon X did not affect viral entry and nuclear translocation of the adenoviral genome but reduced viral DNA production. Conclusion: Stilbene derivatives like Kuwanon X from mulberry leaves are good candidates for antiviral treatment against AdV.

    Tweetable abstract

    Compound from mulberry leaves shows highly inhibitory effect against human AdV.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Fu Y, Tang Z, Ye Z et al. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect. Dis. 19(1), 36 (2019).
    • 2. Hu K, Fu M, Guan X et al. Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses. Vaccine 36(29), 4287–4297 (2018).
    • 3. Dotan M, Zion E, Bilavsky E et al. Adenovirus can be a serious, life-threatening disease, even in previously healthy children. Acta Paediatr. 111(3), 614–619 (2022).
    • 4. Xie L, Zhang B, Xiao N et al. Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China. J. Med. Virol. 91(3), 392–400 (2019).
    • 5. Jin Y, Zhang RF, Xie ZP et al. Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China. Virol. J. 10, 271 (2013).
    • 6. Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin. Respir. Crit. Care Med. 37(4), 586–602 (2016).
    • 7. Dodge MJ, Macneil KM, Tessier TM, Weinberg JB, Mymryk JS. Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies. Antivir. Res. 188, 105034 (2021).
    • 8. Kuwatsuka Y, Atsuta Y, Hirakawa A et al. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection. Int. J. Hematol. 112(6), 841–850 (2020).
    • 9. Lopez SMC, Michaels MG, Green M. Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way? Curr. Opin. Organ Transplant. 23(4), 395–399 (2018).
    • 10. Wen P, Hu T-G, Linhardt RJ, Liao S-T, Wu H, Zou Y-X. Mulberry: a review of bioactive compounds and advanced processing technology. Trends Food Sci. Technol. 83, 138–158 (2019).
    • 11. Afrin S, Giampieri F, Forbes-Hernández TY et al. Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. Free Radic. Biol. Med. 126, 41–54 (2018).
    • 12. Baranauskaite J, Kubiliene A, Marksa M et al. The influence of different oregano species on the antioxidant activity determined using HPLC postcolumn DPPH method and anticancer activity of carvacrol and rosmarinic acid. BioMed. Res. Int. 2017, 1681392 (2017).
    • 13. Sharma A, Kashyap D, Sak K, Tuli HS, Sharma AK. Therapeutic charm of quercetin and its derivatives: a review of research and patents. Pharm. Pat. Anal. 7(1), 15–32 (2018).
    • 14. Ma G, Chai X, Hou G, Zhao F, Meng Q. Phytochemistry, bioactivities and future prospects of mulberry leaves: a review. Food Chem. 372, 131335 (2022).
    • 15. Kim H-B, Lim JD, Kim A-J, Kim Y-S, Kwon O-C. Comparison with various mulberry leaves' and fruit's extract in lipid accumulation inhibitory effect at adipocyte model. Int. J. Indust. Entomol. 35(1), 1–6 (2017). • Demonstrates the inhibitory effect of extracts from mulberry leaves on a adipocyte model.
    • 16. Gryn-Rynko A, Bazylak G, Olszewska-Slonina D. New potential phytotherapeutics obtained from white mulberry (Morus alba L.) leaves. Biomed. Pharmacother. 84, 628–636 (2016).
    • 17. He X, Fang J, Ruan Y et al. Structures, bioactivities and future prospective of polysaccharides from Morus alba (white mulberry): a review. Food Chem. 245, 899–910 (2018). • A review on compounds with bioactivity from mulberry leaves.
    • 18. Li F, Zhang B, Chen G, Fu X. The novel contributors of anti-diabetic potential in mulberry polyphenols revealed by UHPLC-HR-ESI-TOF-MS/MS. Food Rev. Int. 100, 873–884 (2017).
    • 19. Zhang D-Y, Wan Y, Hao J-Y et al. Evaluation of the alkaloid, polyphenols, and antioxidant contents of various mulberry cultivars from different planting areas in eastern China. Ind. Crops Prod. 122, 298–307 (2018).
    • 20. Ma F, Shen W, Zhang X et al. Anti-HSV activity of Kuwanon X from mulberry leaves with genes expression inhibitory and HSV-1 induced NF-κB deactivated properties. Biol. Pharm. Bull. 39(10), 1667–1674 (2016). •• Shows the antiviral activity of Kuwanon X.
    • 21. Zou L, Yi L, Yu J et al. Adenovirus infection in children hospitalized with pneumonia in Guangzhou, China. Influenza Other Respir. Viruses 15(1), 27–33 (2021).
    • 22. Qi L, Wang Y, Wang H, Deng J. Adenovirus 7 induces interlukin-6 expression in human airway epithelial cells via p38/NF-κB signaling pathway. Front. Immunol. 11, 551413 (2020).
    • 23. Yu P, Lou D, Qi L, Chen Z. The novel antiviral properties of brassicasterol against human adenovirus. Future Virol. 16(9), 591–600 (2021). • Shows the anti-AdV activity of other natural products.
    • 24. Wang K, Huang S, Kapoor-Munshi A, Nemerow G. Adenovirus internalization and infection require dynamin. J. Virol. 72(4), 3455–3458 (1998).
    • 25. Lee JA, Kim NH, Kim SJ, Choi EH, Lee HJ. Rapid identification of human adenovirus types 3 and 7 from respiratory specimens via multiplex type-specific PCR. J. Clin. Microbiol. 43(11), 5509–5514 (2005).
    • 26. Schreiner S, Martinez R, Groitl P et al. Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog. 8(2), e1002549 (2012).
    • 27. Marrugal-Lorenzo JA, Serna-Gallego A, González-González L et al. Inhibition of adenovirus infection by mifepristone. Antivir. Res. 159, 77–83 (2018).
    • 28. Pushpakom S, Iorio F, Eyers PA et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18(1), 41–58 (2019).
    • 29. Ali-Seyed M, Jantan I, Vijayaraghavan K, Bukhari SNA. Betulinic acid: recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising anticancer therapy. Chem. Biol. Drug Des. 87(4), 517–536 (2016).
    • 30. Baltina L. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr. Med. Chem. 10(2), 155–171 (2003).